Hyperhomocysteinemia: Genetic determinants and selected mouse models

Clinical and Investigative Medicine

Volumn 26, Issue 3, 2003, Pages 121-132

  Gilfix, Brian M ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Animal; Cystathionine beta synthase; Folic acid; Genes; Homocysteine; Homocystinuria; Hyperhomocys teinemia; Mice; Models; Polymorphism (genetics); Review; Transcabolamins; Vitamin B 12

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENOSINE DEAMINASE; ADENOSYLHOMOCYSTEINASE; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; BINDING PROTEIN; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; GAMMA GLUTAMYL HYDROLASE; HOMOCYSTEINE; METHIONINE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; OXIDOREDUCTASE; REDUCED FOLATE CARRIER; THYMIDYLATE SYNTHASE; TRANSCOBALAMIN II; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; CANCER; CARDIOVASCULAR DISEASE; DISEASE CONTROL; DISEASE MODEL; DISEASE SEVERITY; ENZYME DEFICIENCY; EXPERIMENTAL MOUSE; GENE FUNCTION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETICS; HOMOZYGOTE; HUMAN; HYPERHOMOCYSTEINEMIA; INBORN ERROR OF METABOLISM; INCIDENCE; LETHAL MUTANT; MOUSE MUTANT; MOUSE STRAIN; NEURAL TUBE DEFECT; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; REVIEW; TANDEM REPEAT;

ADENOSINE DEAMINASE; ANIMALS; DISEASE MODELS, ANIMAL; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MICE; MODELS, BIOLOGICAL; POLYMORPHISM, GENETIC; TIME FACTORS;

EID: 0041427757     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Jacobsen DW. Homocysteine and vitamins in cardiovascular disease. Clin Chem 1998;44:1833-43.
2. Kraus JP, Kozich V. Cystathionine β-synthase and its deficiency. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (UK): Cambridge University Press; 2001. p. 223-43.
3. Rosenblatt DS. Inborn errors of folate and cobalamin metabolism. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (UK): Cambridge University Press; 2001. p. 244-58.
4. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Ann Rev Med 1998;49:31-62.
5. Bloom HJ. Diseases and drugs associated with hyperhomocysteinemia. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (UK): Cambridge University Press; 2001. p. 331-40.
6. Miner SE, Evrovski J, Cole DE. Clinical chemistry and molecular biology of homocysteine metabolism: an update. Clin Biochem 1997;30:189-201.
7. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-50.
8. Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (UK): Cambridge University Press; 2001.
9. Devlin AM, Ling E, Peerson JM, Fernando S, Clarke R. Smith AD, et al. Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum Mol Genet 2000;9:2837-44.
10. 12 levels and its relationship to cardiovascular disease risk. Atherosclerosis 2002;164:269-73.
11. Vargas-Martinez C, Ordovas JM, Wilson PW, Selhub J. The glutamate carboxypeptidase gene II (C>T) polymorphism does not affect folate status in the Framingham Offspring cohort. J Nutr 2002;132:1176-9.
12. Födinger M, Dierkes J, Skoupy S, Röhrer C, Hagen W, Puttinger H, et al. Effect of glutamate carboxypepetidase II and the reduced folate carrier polymorphisms on folate and total homocysteine concentrations in dialysis patients. J Am Soc Nephrol 2003;14:1314-9.
13. Carmel R. Folate deficiency. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (UK): Cambridge University Press; 2001. p. 271-88.
14. Chango A, Emery-Fillon, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, et al. A polymorphism (80G8 in a circle signA) in the reduced folate carrier gene and its association with folate status and hyperhomocysteinemia. Mol Genet Metab 2000;70:310-5.
15. Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 2002;108:1-6.
16. Carmel R. Cobalamin deficiency. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (UK): Cambridge University Press; 2001. p. 289-305.
17. Afman LA, Lievers KJ, van der Put NM, Trijbels FJ, Blom HJ. Single nucleotide polymorphisms in the cobalamin gene: relationship with transcobalamin concentrations and the risk of neural tube defects. Eur J Hum Genet 2002;10:433-8.
18. McCaddon A, Blennow K, Hudson P, Regland B, Hill D. Transcobalamin polymorphism and homocysteine. Blood 2001;98;3497-9.
19. Lievers KJ, Afman LA, Kluijtmans LAJ, Boers GH, Verhoef P, den Heijer M, et al. Polymorphisms in the transcobalamin gene: association with plasma homocysteine in healthy individuals and vascular disease patients. Clin Chem 2002;48:1383-9.
20. Jakubowski H. Biosynthesis and reactions of homocysteine thiolactone. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (UK): Cambridge University Press; 2001. p. 21-31.
21. Jakubowski H, Ambrosius WT, Pratt JH. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis. FEBS Lett 2001;491:35-9.
22. 12) increases risk for spina bifida. Mol Genet Metab 1999;67:317-23.
23. Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001;157:451-6.
24. Leclerc D, Campeau, E, Goyette P, Adjalla CE, Christensen B, Ross M, et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cb1G complementation group of folate/cobalamin disorders. Hum Mol Genet 1996;5:1867-74.
25. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JW, Young IS, et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine. Genet Epidemiol 1999;17:298-309.
26. Rozen R. Polymorphisms of folate and cobalamin metabolism. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (UK): Cambridge University Press; 2001. p. 259-69.
27. Frosst P, Blom HJ, Miols R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
28. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
29. McNulty H, McKinley MC, Wilson B, McPartlin J, Strain JJ, Weir WG, et al. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am J Clin Nutr 2002;76:436-41.
30. Klerk K, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG, et al. MTHFR 677C8 in a circle signT polymorphism and the risk of coronary heart disease. JAMA 2002;288:2023-31.
31. Silberberg J, Dudman N. Methionine loading. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (UK): Cambridge University Press; 2001. p. 212-9.
32. De Stefano V, Dekou V, Nicaud V, Chasse JF, London J, Stansbie D, et al. Linkage disequilibrium at the cystathionine β synthase (CBS) locus and the association between genetic variation at the CBS locus and plasma levels of homocysteine. Ann Hum Genet 1998;62:481-90.
33. Lievers KJ, Kluijtmans LA, Hell SG, Boers GH, Verhoef P, van Oppenraay-Emmerzaal D, et al. A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels. Eur J Hum Genet 2001;9:583-9.
34. Jee SH, Song KS, Shim WH, Kim HK, Suh I, Park JY, et al. Major gene evidence after MTHFR-segregation analysis of serum homocysteine infamilies of patients undergoing coronary angioplasty. Hum Genet 2002;111:128-35.
35. Trinh BN, Ong C, Coetzee GA, Yu MC, Laird P. Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 2002;111:299-302.
36. Brown KS, Kluijtmans LA, Young IS, Woodside J, Yarnell JW, McMaster D, et al. Genetic evidence that nitric oxide modulates homocysteine. Arterioscler Thromb Vasc Biol 2003 Apr 10 [epub ahead of print].
37. Piedrahita JA, Oetama B, Bennett GD, van Waes J, Kamen BA, Richardson J, et al. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet 1999;23:228-32.
38. Clarke S, Banfield K. S-adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (UK): Cambridge University Press; 2001. p. 63-78.
39. x) mutation deletes the S-adenosylhomocysteine hydrolase (Ahcy) gene. EMBO J 1994;13:1806-16.
40. Mira T, Kawazu I, Hirano H, Ohmori O, Janjua N, Shibata K. E1 mice epilepsy show genetic polymorphism for S-adenosyl-L-homocysteine hydrolase. Neurochem Int 2001;38:349-57.
41. Blackburn MR, Datta SK, Kellems RE. Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. J Biol Chem 1998;273:5093-100.
42. Hershfield MS, Kredich NM, Owenby DR, Owenby H, Buckley R. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2′-deoxyadenosine in adenosine deaminase-deficient patients. J Clin Invest 1979;63:807-11.
43. Siest G, Pillot T, Régis-Bailly A, Leininger-Muller B, Steinmetz J, Galtreau MM, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995;41:1068-86.
44. Zang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;258:468-71.
45. Moghadasian MH, McManus BM, Hguyen LB, Shefer S, Nadji M, Godin DV, et al. Pathophysiology of apolipoprotein E deficiency in mice: relevance to apoE-related disorders in humans. FASEB J 2001;15;2623-30.
46. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001;10:433-43.
47. Swanson DA, Liu M, Baker PJ, Garrett L, Stitzel M, Wu J, et al. Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol 2001;21:1058-65.
48. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Maliniw MR, et al. Mice deficient in cystathionine β-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci U S A 1995;92:1585-9.
49. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149-55.
50. Kozich V, Kraus E, de Franchis R, Fowler B, Boers GH, Graham I, et al. Hyperhomocysteinemia in premature arterial disease: examination of cystathionine β-synthase alleles at the molecular level. Hum Mol Genet 1995;4;623-9.
51. Lentz SR, Erger RA, Dayal S, Maeda N, Malinow MR, Heistad, DD, et al. Folate dependence of hyperhomocysteinemia and vascular dysfunction on cystathionine β-synthase-deficient mice. Am J Physiol Heart Circ Physiol 2000;279:H970-5.
52. Caudill MA, Wang JC, Melnyk S, Pogribny IP, Jernigan S, Collins MD, et al. Intracellular S-adeosylhomocystine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J Nutr 2001;131:2811-8.
53. Eskes TK. Homocysteine and human reproduction. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (UK): Cambridge University Press; 2001. p. 451-65.
54. Molloy AM, Weir DG. Homocysteine and the nervous system. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (UK): Cambridge University Press; 2001. p. 183-97.
55. Juriloff DM, Harris MJ. Mouse models for neural tube closure defects. Hum Mol Genet 2000;9:993-1000.
56. Carter M, Ulrich S, Oofuji Y, Williams DA, Ross ME. Crooked tail (Cd) models human folate-responsive neural tube defects. Hum Mol Genet 1999;8:2199-204.
57. Ernest S, Christensen B, Gilfix BM, Mamer OA, Hosack A, Rodier M, et al. Genetic and molecular control of folate-homocysteine metabolism in mutant mice. Mamm Genome 2002;13:259-67.
58. Nadeau JH, Frankel WN. The roads from phenotypic variation to gene discovery: mutagensis versus QTLs. Nat Genet 2000;25:381-4.